1992-2021 年全球、地区和国家层面肺癌负担及其风险因素的长期时空趋势:2021 年全球疾病负担研究》。

IF 20.1 1区 医学 Q1 ONCOLOGY
Zegui Tu, Shuangsi Liao, Caini Chen, Caili Li, Qipeng Hu, Chengzhi Cai, Yang Yu, Jieyan Luo, Meijuan Huang
{"title":"1992-2021 年全球、地区和国家层面肺癌负担及其风险因素的长期时空趋势:2021 年全球疾病负担研究》。","authors":"Zegui Tu,&nbsp;Shuangsi Liao,&nbsp;Caini Chen,&nbsp;Caili Li,&nbsp;Qipeng Hu,&nbsp;Chengzhi Cai,&nbsp;Yang Yu,&nbsp;Jieyan Luo,&nbsp;Meijuan Huang","doi":"10.1002/cac2.12622","DOIUrl":null,"url":null,"abstract":"<p>Lung cancer is among the most common types of malignant tumors and continues to be the primary cause of cancer-related death [<span>1</span>]. Despite many striking advances in disease understanding and novel treatment opinions that have occurred in recent years, the survival of lung cancer continues to be low, which causes an important public health and socioeconomic issue [<span>2</span>]. Previous studies have reported estimates of lung cancer burden before 2019 [<span>3, 4</span>]. However, the latest information on lung cancer including data during the COVID-19 pandemic is lacking. It is important to regularly measure the current trends in lung cancer incidence rate, mortality rate, disability-adjusted life-years (DALYs) rate, and risk factors. This information is crucial for updating health policies to adapt to the fast-changing global health landscape during the COVID-19 pandemic.</p><p>To address the above issues, we utilized the latest Global Burden of Diseases (GBD) 2021 data to update statistics on lung cancer incidence, mortality, and DALYs at global, regional, and national levels during 1992-2021 (Supplementary Materials and Methods) [<span>5</span>]. On a global scale, there was a 75.60% increase in the estimated number of lung cancer incident cases, a 60.15% increase in death cases, and a 49.88% increase in DALYs from 1992 to 2021 (Supplementary Table S1). However, the corresponding age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) had decreased trends (Supplementary Table S2). We found that the trend was not consistent worldwide. The region with a high-middle socio-demographic index (SDI) had the highest number of lung cancer incident cases, death cases, and DALYs in 2021 (Supplementary Table S1). Only the low-middle SDI region experienced an increasing trend in age-standardized rates (ASRs) from 1992 to 2021 (Supplementary Table S2). Whereas, the highest ASIR, ASMR, and ASDR of lung cancer were in the middle-SDI region (Supplementary Table S1). At the country level, compared with 1992, most countries presented a slight downward trend in ASIR, ASMR, and ASDR in 2021. China ranked first in the incidence of lung cancer cases, followed by the United States of America and Japan in 2021 (Figure 1A, Supplementary Table S3). China, the United States of America, and India ranked in the top 3 in death cases and DALYs in 2021 (Figure 1B-C, Supplementary Tables S4 and S5). Monaco, Greenland, and Montenegro reported the highest ASIR, ASMR, and ASDR in 2021 (Figure 1D-F, Supplementary Tables S3-S5). However, Egypt had the largest increase in ASIR, ASMR, and ASDR from 1992 to 2021, followed by Lesotho and Cabo Verde (Figure 1G-I, Supplementary Tables S3-S5). Additionally, in 2021, the rates of lung cancer incidence, mortality, and DALYs in males were 2.23, 2.36, and 2.31 times higher than those in females (Supplementary Figure S1). The ASIR, ASMR, and ASDR of lung cancer in males presented a decrease from 1992 to 2021, while the ASIR, ASMR, and ASDR of lung cancer in females remain nearly stable (Supplementary Figure S2). The largest proportion of individuals affected by lung cancer are over the age of 50, and there has been an upward trend in the number of cases, mortality, and distribution of DALYs among this age group over the past 30 years (Supplementary Figure S3).</p><p>To better understand the impact of age, period, and birth cohort on lung cancer incidence, mortality, and DALY rates over the last 30 years, we next performed age-period-cohort analyses. Our results showed that, globally, a net drift of lung cancer incidence, mortality, and DALYs for the whole population was -1.14%, -1.47%, and -1.46% per year, respectively (Supplementary Figure S4, Supplementary Table S6). The local drifts of lung cancer incidence were above zero for the ages of 75 to 79 (Supplementary Figure S4, Supplementary Table S7). Similar age trends of lung cancer were observed across different SDI quintiles. Generally, the risk for lung cancer significantly grew with age and the age effects for females were significantly lower than for males (Supplementary Figure S5). Period effects showed different patterns across different SDI quintiles over the study period (Supplementary Figure S6). At the global level and in high-SDI countries, the period effect of incidence, mortality, and DALYs rate decreased over time, and the reduction in risk over time was less for females compared to males. Only in regions with low-middle SDI did the incidence rate continue to increase from 1992 to 2021. When looking at the cohort effect, there is a significant decrease in Cohort trends of lung cancer, particularly in the global, middle-SDI, high-middle SDI, and high-SDI regions (Supplementary Figure S7). From the earlier birth cohort to the later birth cohort, there was an upward trend in females in regions with low-middle SDI, while males in low-middle SDI remained nearly constant. In low SDI, females show a trend of rising, and males show a trend of declining.</p><p>We further estimated the lung cancer burden caused by risk factors to prioritize public health interventions (Supplementary Figures S8 and S9). From 1992 to 2021, the proportion of high fasting plasma glucose and ambient particulate matter pollution steadily increased as global risk factors for lung cancer. Smoking still remains the highest proportion in 2021, followed by occupational exposure to asbestos. However, over time, the proportion of smoking and occupational exposure to asbestos has gradually decreased. The changing trend of the proportion of risk factors in lung cancer presented different trends in different SDI regions. In high SDI areas, occupational exposure to asbestos and high fasting plasma glucose are higher than those in other areas and the proportion of occupational exposure to silica is decreasing year by year. In the high middle SDI area, smoking, secondhand smoke, and residential radon make up a relatively high proportion. In the middle SDI area, the proportion of ambient particulate matter pollution was higher than those in other areas. In regions with low SDI and low-middle SDI, the highest proportion was a diet low in fruits and household air pollution from solid fuels.</p><p>In conclusion, over the past 30 years, despite a global downward trend in ASIR, ASMR, and ASDR of lung cancer, it remains a significant burden worldwide. The significant differences in ASIR, ASMR, ASDR, and risk factors among countries and territories remained a key epidemiological characteristic of lung cancer. This suggests that each government should adopt flexible health policies and allocate medical resources reasonably to improve their healthcare systems in order to address the diverse needs related to lung cancer. Global strategies for improving air quality, tobacco control, promoting clean cooking fuels, and reducing occupational hazards are vital for reducing the burden of lung cancer. All comprehensive and comparable estimates provided in this study can serve as a data basis for further scientific research and facilitate valid comparisons among different areas.</p><p>The authors declare no conflict of interest.</p><p>Not applicable.</p><p>Not applicable.</p>","PeriodicalId":9495,"journal":{"name":"Cancer Communications","volume":"44 12","pages":"1418-1421"},"PeriodicalIF":20.1000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cac2.12622","citationCount":"0","resultStr":"{\"title\":\"The long-term spatiotemporal trends in lung cancer burden and its risk factors at global, regional, and national levels, 1992-2021: The Global Burden of Disease Study 2021\",\"authors\":\"Zegui Tu,&nbsp;Shuangsi Liao,&nbsp;Caini Chen,&nbsp;Caili Li,&nbsp;Qipeng Hu,&nbsp;Chengzhi Cai,&nbsp;Yang Yu,&nbsp;Jieyan Luo,&nbsp;Meijuan Huang\",\"doi\":\"10.1002/cac2.12622\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Lung cancer is among the most common types of malignant tumors and continues to be the primary cause of cancer-related death [<span>1</span>]. Despite many striking advances in disease understanding and novel treatment opinions that have occurred in recent years, the survival of lung cancer continues to be low, which causes an important public health and socioeconomic issue [<span>2</span>]. Previous studies have reported estimates of lung cancer burden before 2019 [<span>3, 4</span>]. However, the latest information on lung cancer including data during the COVID-19 pandemic is lacking. It is important to regularly measure the current trends in lung cancer incidence rate, mortality rate, disability-adjusted life-years (DALYs) rate, and risk factors. This information is crucial for updating health policies to adapt to the fast-changing global health landscape during the COVID-19 pandemic.</p><p>To address the above issues, we utilized the latest Global Burden of Diseases (GBD) 2021 data to update statistics on lung cancer incidence, mortality, and DALYs at global, regional, and national levels during 1992-2021 (Supplementary Materials and Methods) [<span>5</span>]. On a global scale, there was a 75.60% increase in the estimated number of lung cancer incident cases, a 60.15% increase in death cases, and a 49.88% increase in DALYs from 1992 to 2021 (Supplementary Table S1). However, the corresponding age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) had decreased trends (Supplementary Table S2). We found that the trend was not consistent worldwide. The region with a high-middle socio-demographic index (SDI) had the highest number of lung cancer incident cases, death cases, and DALYs in 2021 (Supplementary Table S1). Only the low-middle SDI region experienced an increasing trend in age-standardized rates (ASRs) from 1992 to 2021 (Supplementary Table S2). Whereas, the highest ASIR, ASMR, and ASDR of lung cancer were in the middle-SDI region (Supplementary Table S1). At the country level, compared with 1992, most countries presented a slight downward trend in ASIR, ASMR, and ASDR in 2021. China ranked first in the incidence of lung cancer cases, followed by the United States of America and Japan in 2021 (Figure 1A, Supplementary Table S3). China, the United States of America, and India ranked in the top 3 in death cases and DALYs in 2021 (Figure 1B-C, Supplementary Tables S4 and S5). Monaco, Greenland, and Montenegro reported the highest ASIR, ASMR, and ASDR in 2021 (Figure 1D-F, Supplementary Tables S3-S5). However, Egypt had the largest increase in ASIR, ASMR, and ASDR from 1992 to 2021, followed by Lesotho and Cabo Verde (Figure 1G-I, Supplementary Tables S3-S5). Additionally, in 2021, the rates of lung cancer incidence, mortality, and DALYs in males were 2.23, 2.36, and 2.31 times higher than those in females (Supplementary Figure S1). The ASIR, ASMR, and ASDR of lung cancer in males presented a decrease from 1992 to 2021, while the ASIR, ASMR, and ASDR of lung cancer in females remain nearly stable (Supplementary Figure S2). The largest proportion of individuals affected by lung cancer are over the age of 50, and there has been an upward trend in the number of cases, mortality, and distribution of DALYs among this age group over the past 30 years (Supplementary Figure S3).</p><p>To better understand the impact of age, period, and birth cohort on lung cancer incidence, mortality, and DALY rates over the last 30 years, we next performed age-period-cohort analyses. Our results showed that, globally, a net drift of lung cancer incidence, mortality, and DALYs for the whole population was -1.14%, -1.47%, and -1.46% per year, respectively (Supplementary Figure S4, Supplementary Table S6). The local drifts of lung cancer incidence were above zero for the ages of 75 to 79 (Supplementary Figure S4, Supplementary Table S7). Similar age trends of lung cancer were observed across different SDI quintiles. Generally, the risk for lung cancer significantly grew with age and the age effects for females were significantly lower than for males (Supplementary Figure S5). Period effects showed different patterns across different SDI quintiles over the study period (Supplementary Figure S6). At the global level and in high-SDI countries, the period effect of incidence, mortality, and DALYs rate decreased over time, and the reduction in risk over time was less for females compared to males. Only in regions with low-middle SDI did the incidence rate continue to increase from 1992 to 2021. When looking at the cohort effect, there is a significant decrease in Cohort trends of lung cancer, particularly in the global, middle-SDI, high-middle SDI, and high-SDI regions (Supplementary Figure S7). From the earlier birth cohort to the later birth cohort, there was an upward trend in females in regions with low-middle SDI, while males in low-middle SDI remained nearly constant. In low SDI, females show a trend of rising, and males show a trend of declining.</p><p>We further estimated the lung cancer burden caused by risk factors to prioritize public health interventions (Supplementary Figures S8 and S9). From 1992 to 2021, the proportion of high fasting plasma glucose and ambient particulate matter pollution steadily increased as global risk factors for lung cancer. Smoking still remains the highest proportion in 2021, followed by occupational exposure to asbestos. However, over time, the proportion of smoking and occupational exposure to asbestos has gradually decreased. The changing trend of the proportion of risk factors in lung cancer presented different trends in different SDI regions. In high SDI areas, occupational exposure to asbestos and high fasting plasma glucose are higher than those in other areas and the proportion of occupational exposure to silica is decreasing year by year. In the high middle SDI area, smoking, secondhand smoke, and residential radon make up a relatively high proportion. In the middle SDI area, the proportion of ambient particulate matter pollution was higher than those in other areas. In regions with low SDI and low-middle SDI, the highest proportion was a diet low in fruits and household air pollution from solid fuels.</p><p>In conclusion, over the past 30 years, despite a global downward trend in ASIR, ASMR, and ASDR of lung cancer, it remains a significant burden worldwide. The significant differences in ASIR, ASMR, ASDR, and risk factors among countries and territories remained a key epidemiological characteristic of lung cancer. This suggests that each government should adopt flexible health policies and allocate medical resources reasonably to improve their healthcare systems in order to address the diverse needs related to lung cancer. Global strategies for improving air quality, tobacco control, promoting clean cooking fuels, and reducing occupational hazards are vital for reducing the burden of lung cancer. All comprehensive and comparable estimates provided in this study can serve as a data basis for further scientific research and facilitate valid comparisons among different areas.</p><p>The authors declare no conflict of interest.</p><p>Not applicable.</p><p>Not applicable.</p>\",\"PeriodicalId\":9495,\"journal\":{\"name\":\"Cancer Communications\",\"volume\":\"44 12\",\"pages\":\"1418-1421\"},\"PeriodicalIF\":20.1000,\"publicationDate\":\"2024-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cac2.12622\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Communications\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cac2.12622\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Communications","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cac2.12622","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

肺癌是最常见的恶性肿瘤之一,也是癌症相关死亡的主要原因。尽管近年来在疾病认识和新的治疗意见方面取得了许多惊人的进展,但肺癌的存活率仍然很低,这导致了一个重要的公共卫生和社会经济问题bbb。先前的研究报告了2019年之前的肺癌负担估计数[3,4]。但是,包括新冠肺炎大流行期间的数据在内,缺乏有关肺癌的最新信息。定期测量肺癌发病率、死亡率、伤残调整生命年(DALYs)率和危险因素的当前趋势非常重要。这些信息对于更新卫生政策以适应2019冠状病毒病大流行期间快速变化的全球卫生格局至关重要。为了解决上述问题,我们利用最新的全球疾病负担(GBD) 2021数据来更新1992-2021年间全球、地区和国家各级肺癌发病率、死亡率和DALYs的统计数据(补充材料和方法)bbb。在全球范围内,从1992年到2021年,肺癌发病病例的估计数量增加了75.60%,死亡病例增加了60.15%,DALYs增加了49.88%(补充表S1)。然而,相应的年龄标准化发病率(ASIR)、年龄标准化死亡率(ASMR)和年龄标准化DALYs率(ASDR)呈下降趋势(补充表S2)。我们发现这一趋势在世界范围内并不一致。社会人口指数(SDI)中高的地区在2021年的肺癌发病率、死亡病例和DALYs数量最高(补充表S1)。从1992年到2021年,只有中低SDI地区的年龄标准化率(ASRs)呈上升趋势(补充表S2)。而肺癌的ASIR、ASMR和ASDR在sdi中部地区最高(补充表S1)。在国家层面,与1992年相比,大多数国家在2021年的ASIR、ASMR和ASDR呈轻微下降趋势。中国在2021年肺癌发病率中排名第一,其次是美国和日本(图1A,补充表S3)。中国、美利坚合众国和印度在2021年死亡病例和伤残调整生命年排名前三(图1B-C,补充表S4和S5)。摩纳哥、格陵兰岛和黑山报告了2021年最高的ASIR、ASMR和ASDR(图1D-F,补充表S3-S5)。然而,从1992年到2021年,埃及的ASIR、ASMR和ASDR增幅最大,其次是莱索托和佛得角(图g - 1,补充表S3-S5)。此外,在2021年,男性的肺癌发病率、死亡率和DALYs分别是女性的2.23倍、2.36倍和2.31倍(补充图S1)。从1992年到2021年,男性肺癌的ASIR、ASMR和ASDR呈下降趋势,而女性肺癌的ASIR、ASMR和ASDR基本保持稳定(补充图S2)。50岁以上的肺癌患者所占比例最大。在过去30年,这一年龄组的病例数、死亡率和伤残调整生命年的分布均呈上升趋势(补充图S3)。为了更好地了解年龄、时期和出生队列对过去30年肺癌发病率、死亡率和DALY率的影响,我们接下来进行了年龄-时期-队列分析。我们的研究结果显示,在全球范围内,整个人群的肺癌发病率、死亡率和DALYs的净漂移分别为每年-1.14%、-1.47%和-1.46%(补充图S4,补充表S6)。75 ~ 79岁肺癌发病率的局部漂移均大于零(补充图S4,补充表S7)。在不同的SDI五分位数中观察到相似的肺癌年龄趋势。一般来说,肺癌的风险随着年龄的增长而显著增加,女性的年龄效应明显低于男性(补充图S5)。在研究期间,不同SDI五分位数的周期效应表现出不同的模式(补充图S6)。在全球水平和高sdi国家,发病率、死亡率和DALYs率的时期效应随着时间的推移而降低,女性的风险降低程度低于男性。从1992年到2021年,只有在SDI中低的地区,发病率继续增加。当观察队列效应时,肺癌的队列趋势显著下降,特别是在全球、中等SDI、高中等SDI和高SDI地区(补充图S7)。从较早出生队列到较晚出生队列,中低SDI地区的女性SDI呈上升趋势,而中低SDI地区的男性SDI几乎保持不变。 在低SDI区,女性呈上升趋势,男性呈下降趋势。我们进一步估计了由危险因素引起的肺癌负担,以优先考虑公共卫生干预措施(补充图S8和S9)。1992年至2021年,空腹血糖过高和环境颗粒物污染作为全球肺癌危险因素的比例稳步上升。2021年,吸烟的比例仍然最高,其次是职业接触石棉。然而,随着时间的推移,吸烟和职业接触石棉的比例逐渐下降。肺癌危险因素占比的变化趋势在不同SDI地区呈现出不同的趋势。在SDI高的地区,职业暴露于石棉和空腹血糖高的比例高于其他地区,职业暴露于二氧化硅的比例呈逐年下降趋势。在中高SDI地区,吸烟、二手烟和居住氡占比较高的比例。在SDI中部区域,环境颗粒物污染比例高于其他区域。在低SDI和中低SDI地区,比例最高的是低水果饮食和固体燃料造成的家庭空气污染。总之,在过去30年中,尽管肺癌的ASIR、ASMR和ASDR在全球呈下降趋势,但它仍然是世界范围内的一个重大负担。不同国家和地区之间ASIR、ASMR、ASDR和危险因素的显著差异仍然是肺癌的关键流行病学特征。建议各国政府应采取灵活的卫生政策,合理配置医疗资源,以改善其医疗体系,以满足与肺癌相关的多样化需求。改善空气质量、烟草控制、推广清洁烹饪燃料和减少职业危害的全球战略对于减轻肺癌负担至关重要。本研究提供的所有综合的、可比较的估计都可以作为进一步科学研究的数据基础,并促进不同领域之间的有效比较。作者声明无利益冲突。不适用。不适用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The long-term spatiotemporal trends in lung cancer burden and its risk factors at global, regional, and national levels, 1992-2021: The Global Burden of Disease Study 2021

The long-term spatiotemporal trends in lung cancer burden and its risk factors at global, regional, and national levels, 1992-2021: The Global Burden of Disease Study 2021

Lung cancer is among the most common types of malignant tumors and continues to be the primary cause of cancer-related death [1]. Despite many striking advances in disease understanding and novel treatment opinions that have occurred in recent years, the survival of lung cancer continues to be low, which causes an important public health and socioeconomic issue [2]. Previous studies have reported estimates of lung cancer burden before 2019 [3, 4]. However, the latest information on lung cancer including data during the COVID-19 pandemic is lacking. It is important to regularly measure the current trends in lung cancer incidence rate, mortality rate, disability-adjusted life-years (DALYs) rate, and risk factors. This information is crucial for updating health policies to adapt to the fast-changing global health landscape during the COVID-19 pandemic.

To address the above issues, we utilized the latest Global Burden of Diseases (GBD) 2021 data to update statistics on lung cancer incidence, mortality, and DALYs at global, regional, and national levels during 1992-2021 (Supplementary Materials and Methods) [5]. On a global scale, there was a 75.60% increase in the estimated number of lung cancer incident cases, a 60.15% increase in death cases, and a 49.88% increase in DALYs from 1992 to 2021 (Supplementary Table S1). However, the corresponding age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) had decreased trends (Supplementary Table S2). We found that the trend was not consistent worldwide. The region with a high-middle socio-demographic index (SDI) had the highest number of lung cancer incident cases, death cases, and DALYs in 2021 (Supplementary Table S1). Only the low-middle SDI region experienced an increasing trend in age-standardized rates (ASRs) from 1992 to 2021 (Supplementary Table S2). Whereas, the highest ASIR, ASMR, and ASDR of lung cancer were in the middle-SDI region (Supplementary Table S1). At the country level, compared with 1992, most countries presented a slight downward trend in ASIR, ASMR, and ASDR in 2021. China ranked first in the incidence of lung cancer cases, followed by the United States of America and Japan in 2021 (Figure 1A, Supplementary Table S3). China, the United States of America, and India ranked in the top 3 in death cases and DALYs in 2021 (Figure 1B-C, Supplementary Tables S4 and S5). Monaco, Greenland, and Montenegro reported the highest ASIR, ASMR, and ASDR in 2021 (Figure 1D-F, Supplementary Tables S3-S5). However, Egypt had the largest increase in ASIR, ASMR, and ASDR from 1992 to 2021, followed by Lesotho and Cabo Verde (Figure 1G-I, Supplementary Tables S3-S5). Additionally, in 2021, the rates of lung cancer incidence, mortality, and DALYs in males were 2.23, 2.36, and 2.31 times higher than those in females (Supplementary Figure S1). The ASIR, ASMR, and ASDR of lung cancer in males presented a decrease from 1992 to 2021, while the ASIR, ASMR, and ASDR of lung cancer in females remain nearly stable (Supplementary Figure S2). The largest proportion of individuals affected by lung cancer are over the age of 50, and there has been an upward trend in the number of cases, mortality, and distribution of DALYs among this age group over the past 30 years (Supplementary Figure S3).

To better understand the impact of age, period, and birth cohort on lung cancer incidence, mortality, and DALY rates over the last 30 years, we next performed age-period-cohort analyses. Our results showed that, globally, a net drift of lung cancer incidence, mortality, and DALYs for the whole population was -1.14%, -1.47%, and -1.46% per year, respectively (Supplementary Figure S4, Supplementary Table S6). The local drifts of lung cancer incidence were above zero for the ages of 75 to 79 (Supplementary Figure S4, Supplementary Table S7). Similar age trends of lung cancer were observed across different SDI quintiles. Generally, the risk for lung cancer significantly grew with age and the age effects for females were significantly lower than for males (Supplementary Figure S5). Period effects showed different patterns across different SDI quintiles over the study period (Supplementary Figure S6). At the global level and in high-SDI countries, the period effect of incidence, mortality, and DALYs rate decreased over time, and the reduction in risk over time was less for females compared to males. Only in regions with low-middle SDI did the incidence rate continue to increase from 1992 to 2021. When looking at the cohort effect, there is a significant decrease in Cohort trends of lung cancer, particularly in the global, middle-SDI, high-middle SDI, and high-SDI regions (Supplementary Figure S7). From the earlier birth cohort to the later birth cohort, there was an upward trend in females in regions with low-middle SDI, while males in low-middle SDI remained nearly constant. In low SDI, females show a trend of rising, and males show a trend of declining.

We further estimated the lung cancer burden caused by risk factors to prioritize public health interventions (Supplementary Figures S8 and S9). From 1992 to 2021, the proportion of high fasting plasma glucose and ambient particulate matter pollution steadily increased as global risk factors for lung cancer. Smoking still remains the highest proportion in 2021, followed by occupational exposure to asbestos. However, over time, the proportion of smoking and occupational exposure to asbestos has gradually decreased. The changing trend of the proportion of risk factors in lung cancer presented different trends in different SDI regions. In high SDI areas, occupational exposure to asbestos and high fasting plasma glucose are higher than those in other areas and the proportion of occupational exposure to silica is decreasing year by year. In the high middle SDI area, smoking, secondhand smoke, and residential radon make up a relatively high proportion. In the middle SDI area, the proportion of ambient particulate matter pollution was higher than those in other areas. In regions with low SDI and low-middle SDI, the highest proportion was a diet low in fruits and household air pollution from solid fuels.

In conclusion, over the past 30 years, despite a global downward trend in ASIR, ASMR, and ASDR of lung cancer, it remains a significant burden worldwide. The significant differences in ASIR, ASMR, ASDR, and risk factors among countries and territories remained a key epidemiological characteristic of lung cancer. This suggests that each government should adopt flexible health policies and allocate medical resources reasonably to improve their healthcare systems in order to address the diverse needs related to lung cancer. Global strategies for improving air quality, tobacco control, promoting clean cooking fuels, and reducing occupational hazards are vital for reducing the burden of lung cancer. All comprehensive and comparable estimates provided in this study can serve as a data basis for further scientific research and facilitate valid comparisons among different areas.

The authors declare no conflict of interest.

Not applicable.

Not applicable.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Communications
Cancer Communications Biochemistry, Genetics and Molecular Biology-Cancer Research
CiteScore
25.50
自引率
4.30%
发文量
153
审稿时长
4 weeks
期刊介绍: Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信